152 related articles for article (PubMed ID: 37284297)
21. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
[TBL] [Abstract][Full Text] [Related]
22. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC).
Gregor A; Cull A; Stephens RJ; Kirkpatrick JA; Yarnold JR; Girling DJ; Macbeth FR; Stout R; Machin D
Eur J Cancer; 1997 Oct; 33(11):1752-8. PubMed ID: 9470828
[TBL] [Abstract][Full Text] [Related]
24. Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; Repka MC; Kappes J; Thomas M; Bischoff H; Herth F; Heußel CP; Debus J; Steins M; Rieken S
Clin Lung Cancer; 2017 Jul; 18(4):e267-e271. PubMed ID: 28027850
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer.
Kim H; Keller A; Beriwal S; Smith KJ; Vargo JA
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1186-1194. PubMed ID: 33984410
[TBL] [Abstract][Full Text] [Related]
26. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Lenz HJ; Argiles G; Yoshino T; Lonardi S; Falcone A; Limón ML; Sobrero A; Hastedt C; Peil B; Voss F; Griebsch I; Van Cutsem E
Clin Colorectal Cancer; 2019 Dec; 18(4):269-279.e5. PubMed ID: 31628043
[TBL] [Abstract][Full Text] [Related]
27. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
28. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
[TBL] [Abstract][Full Text] [Related]
29. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
Hong F; Bosco JL; Bush N; Berry DL
BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.
Zeng H; Hendriks LEL; Witlox WJA; Groen HJM; Dingemans AC; Praag J; Belderbos J; Houben R; van der Noort V; De Ruysscher DKM
Radiother Oncol; 2023 Jun; 183():109627. PubMed ID: 36934893
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
33. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
34. Impact of Hippocampal Avoidance - Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients.
Maragkoudakis E; Kouloulias V; Grenzelia M; Kougioumtzopoulou A; Zygogianni A; Ramfidis V; Charpidou A
Cancer Diagn Progn; 2022; 2(3):279-284. PubMed ID: 35530654
[TBL] [Abstract][Full Text] [Related]
35. Perihippocampal Meningeal Carcinomatosis Following Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Case Report.
Fujiwara M; Tada H
Cureus; 2023 Oct; 15(10):e46499. PubMed ID: 37927701
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?
Crockett C; Belderbos J; Levy A; McDonald F; Le Péchoux C; Faivre-Finn C
Lung Cancer; 2021 Dec; 162():96-105. PubMed ID: 34768007
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic cranial irradiation in SCLC.
Suwinski R
Transl Lung Cancer Res; 2021 Apr; 10(4):2071-2078. PubMed ID: 34012815
[TBL] [Abstract][Full Text] [Related]
39. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
